https://www.selleckchem.com/pr....oducts/zongertinib.h
e, infection, postoperative paresthesia, nerve injury, or any other serious adverse effects in either group. Single-center study, relatively small number of patients. PRF and stSCS are both effective and safe therapeutic alternatives for patients with acute/subacute zoster-related pain, however, stSCS could achieve more pain relief and improvement of life quality compared with PRF. PRF and stSCS are both effective and safe therapeutic alternatives for patients with acute/subacute zoster-related pain, however, stSCS could achieve mor
Aimer
Commentaire
Partagez
